Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery The Phase 2 Nonrandomized QuickSilver Clinical Trial
Erin D Kennedy, Marko Simunovic, Kartik Jhaveri, Richard Kirsch, Jim Brierley, Sebastien Drolet, Carl Brown, Patrick M Vos, Wei Xiong, Tony MacLean, Selliah Kanthan, Peter Stotland, Simon Raphael, Gil Chow, Catherine A O'Brien, Charles Cho, Cathy Streutker, Raimond Wong, Selina Schmocker, Sender Liberman Show all
JAMA Oncology | AMER MEDICAL ASSOC | Published : 2019
This work was supported by a peer reviewed grant from the MSH-UHN Academic Medical Organization Innovation Fund. None of the investigators received any salary support for participating in the project. Travel and accommodation were reimbursed for the Quick Silver investigators' meeting.